| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00259-008-0789-Y |
| P698 | PubMed publication ID | 18418591 |
| P2093 | author name string | Elisa Caballero-Calabuig | |
| Jesús Félix-Fontestad | |||
| Pablo Sopena-Novales | |||
| Pedro Abreu-Sánchez | |||
| Ramón Sopena-Monforte | |||
| José Ferrer-Rebolleda | |||
| Carmen Cano-Terol | |||
| Carmen Plancha-Mansanet | |||
| Dolores Reyes-Ojeda | |||
| P2860 | cites work | Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I whole-body scanning results? | Q33218328 |
| A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. | Q34188774 | ||
| Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer | Q34215677 | ||
| Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients | Q34523261 | ||
| Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective | Q35649218 | ||
| Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer | Q35855096 | ||
| The evolving role of (131)I for the treatment of differentiated thyroid carcinoma | Q36011259 | ||
| Possible explanations for patients with discordant findings of serum thyroglobulin and 131I whole-body scanning | Q36255639 | ||
| European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium | Q36489842 | ||
| Thyroid cancer diagnosis and management. | Q40772977 | ||
| Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patients. | Q43732383 | ||
| Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment. | Q46736702 | ||
| Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. | Q53263951 | ||
| Complications, sequela and dosimetry of iodine-131 therapy for thyroid carcinoma | Q67960618 | ||
| Low levels of serum thyroglobulin after withdrawal of thyroid suppression therapy in the follow up of differentiated thyroid carcinoma | Q68716169 | ||
| Prospective randomized clinical trial to evaluate the optimal dose of 131 I for remnant ablation in patients with differentiated thyroid carcinoma | Q71102237 | ||
| Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer | Q72050897 | ||
| Radioiodine therapy for well-differentiated thyroid cancer: a quantitative dosimetric evaluation for remnant thyroid ablation after surgery | Q72880212 | ||
| Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma | Q73802829 | ||
| Papillary and follicular thyroid carcinoma | Q74100773 | ||
| Procedure guideline for therapy of thyroid disease with (131)iodine | Q74245523 | ||
| The use of radioactive iodine in patients with papillary and follicular thyroid cancer | Q77676711 | ||
| [Controversies in the follow-up and management of well-differentiated thyroid cancer. New answers to old questions] | Q81679343 | ||
| P433 | issue | 8 | |
| P921 | main subject | diagnosis | Q16644043 |
| thyroglobulin | Q20817224 | ||
| iodine in medicine | Q28196266 | ||
| P304 | page(s) | 1449-1456 | |
| P577 | publication date | 2008-04-17 | |
| P1433 | published in | European Journal of Nuclear Medicine and Molecular Imaging | Q15708890 |
| P1476 | title | Influence of the thyroid remnant in the elevation of the serum thyroglobulin after thyroidectomy in differentiated thyroid carcinoma. Importance of the diagnostic iodine total-body scanning | |
| P478 | volume | 35 |
| Q34385052 | Clinical significance of observation without repeated radioiodine therapy in differentiated thyroid carcinoma patients with positive surveillance whole-body scans and negative thyroglobulin. |
| Q39089867 | Implication of different clinical and pathological variables in patients with differentiated thyroid cancer on successful ablation for 3700 MBq (131)I: a single Egyptian institutional experience over 14 years |
| Q39100644 | Nuclear Molecular and Theranostic Imaging for Differentiated Thyroid Cancer |
Search more.